To elucidate the molecular background for the heterogeneity in protein S pl
asma concentrations observed in protein S deficient individuals, the in vit
ro synthesis of recombinant protein S missense mutants was investigated. Si
x different naturally occurring mutations identified in the protein S gene
(PROS1) of thrombosis patients were reproduced in protein S cDNA by site di
rected mutagenesis, Two mutants, G441C and Y444C (group A), were associated
with low total plasma concentration of protein S, Modestly low protein S w
as found in families with R520G and P626L (group B) mutants. T57S and 1518M
(group C), which was associated with marginally low protein S, did not seg
regate with protein S deficiency in the respective families, raising doubts
as to whether they were causative mutations or rare neutral variants. The
6 protein S mutants were transiently expressed in COS1 cells. The Y444C mut
ant showed the lowest level of secretion (2.5%) followed by the G441C mutan
t (40%). Group B demonstrated around 50% reduction in secretion, whereas gr
oup C mutants showed normal secretion. Pulse-chase experiments demonstrated
impaired protein S processing with intracellular degradation and decreased
secretion into the culture media of group A and B mutants. Interestingly,
there was a good correlation between in vitro secretion and the concentrati
on of free protein S in the plasma of heterozygous carriers. These results
demonstrate impaired protein S secretion to be an important mechanism under
lying hereditary protein S deficiency and that variations in protein secret
ion is a major determinant of the phenotypic heterogeneity observed in prot
ein S deficiency. (C) 2000 by The American Society of Hematology.